The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

These four blue chip stocks with dependable, high-yield dividends should continue to deliver regardless of inflation.

Trump's HHS pick could reshape public health agencies and usher in a new era for vaccines, food, and medicines.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.

If confirmed, Robert F. Kennedy Jr. could soon be the secretary of the Department of Health and Human Services, which ...

The announcement that Robert F. Kennedy Jr. was chosen to be the next head of HHS raises many questions about his suitability ...

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...

His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.

Robert F. Kennedy Jr., Trump's pick​ to lead the Department of Health and Human Services, has raised controversy on topics ...

Pharmaceutical and biotech industries essentially use laboratory freeze dryers in their research. Such equipment is employed ...

India has achieved a significant milestone by recording its highest-ever merchandise exports of USD 39.2 billion for October ...